期刊
COLLOID AND INTERFACE SCIENCE COMMUNICATIONS
卷 45, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.colcom.2021.100533
关键词
Nanoemulsions; Biosurfactants; Drug delivery; COVID-19; SARS-CoV-2
Viral diseases are becoming global threats, with the impact of SARS-CoV-2 causing COVID-19 being severe. Further evaluation is needed for the safety, dosage, and potency of vaccines against SARS-CoV-2, as there is still no effective treatment for COVID-19. Oil-in-water nanoemulsions show promise as advanced platforms for drug delivery, with potential for combating evolving diseases like COVID-19.
Viral diseases are emerging as global threats. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), that causes coronavirus disease (COVID-19), has severe global impacts. Safety, dosage, and potency of vaccines recently approved for emergency use against SARS-CoV-2 need further evaluation. There is still no effective treatment against COVID-19; therefore, safe, and effective vaccines or therapeutics against SARS-CoV-2 are urgently needed. Oil-in-water nanoemulsions (O/W NEs) are emerging as sophisticated, protective, and therapeutic platforms. Encapsulation capacity, which offers better drug pharmacokinetics, coupled with the tunable surfaces present NEs as promising tools for pharmaceutical applications. The challenges facing drug discovery, and the advancements of NEs in drug delivery demonstrate the potential of NEs against evolving diseases, like COVID-19. Here we summarize current COVID-19 knowledge and discuss the composition, stability, preparation, characterization, and biological fate of O/W NEs. We also provide insights into NE structural-functional properties that may contribute to therapeutic or preventative solutions against COVID-19.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据